Skip to main content
74°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Inmed Pharmaceuticals Inc
(NQ:
INM
)
0.3977
-0.0138 (-3.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inmed Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 24, 2023
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data.
Via
Benzinga
Crude Oil Down Over 2%; General Motors Posts Upbeat Earnings
October 24, 2023
U.S. stocks traded slightly higher midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.17% to 32,992.95 while the NASDAQ rose 0.06% to 13,023.65....
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positive Proof-of-Concept Results
October 24, 2023
Via
Investor Brand Network
Why InMed Pharmaceuticals Stock Is Soaring Tuesday
October 24, 2023
InMed Pharmaceuticals Inc (NASDAQ: INM) shares are trading higher Tuesday after the company said it selected a lead Alzheimer's drug candidate following positive proof-of-concept study data.
Via
Benzinga
Dow Surges 250 Points; US Manufacturing PMI Tops Expectations
October 24, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 250 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.80% to 33,200.75 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
InMed Pharmaceuticals, A Cannabinoid-Focused Company, Sponsored Benzinga's Cannabis Capital Conference
October 16, 2023
InMed Pharmaceuticals (NASDAQ: INM) is a global leader in researching, developing, manufacturing and commercializing rare cannabinoids and cannabinoid analogs.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Industry Report Highlights Positive Sentiment and Growth Potential at Benzinga Conference
October 13, 2023
Discover key insights from the Benzinga Cannabis Conference, featuring strategies from top firms like MariMed, AYR & InMed!
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases FY 2023 Report, Shares Corporate Update
September 29, 2023
Via
Investor Brand Network
This Clinical Stage BioPharma Is Seeing Solid Growth In Rare Cannabinoid Demand From The Health And Wellness Sector
September 15, 2023
BayMedica, a rare cannabinoids supplier for the health and wellness sector acquired by InMed Pharmaceuticals (NASDAQ: INM) in 2021, is scaling up its manufacturing process to meet growing demand.
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 07, 2023
Via
Investor Brand Network
Cannabis Stock Gainers And Losers From August 25, 2023
August 25, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From July 25, 2023
July 25, 2023
Via
Benzinga
Marijuana Stock Movers For August 22, 2023
August 22, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For July 21, 2023
July 21, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
August 16, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series
July 21, 2023
Via
CannabisNewsWire
Topics
Supply Chain
Exposures
Supply Chain
Marijuana Stock Movers For August 15, 2023
August 15, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series
July 21, 2023
Via
Investor Brand Network
Topics
Supply Chain
Exposures
Supply Chain
Cannabis Stock Gainers And Losers From August 11, 2023
August 11, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business
July 20, 2023
Via
CannabisNewsWire
Topics
Supply Chain
Exposures
Supply Chain
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business
July 20, 2023
Via
Investor Brand Network
Topics
Supply Chain
Exposures
Supply Chain
Marijuana Stock Movers For August 8, 2023
August 08, 2023
Via
Benzinga
Game-Changer In Epidermolysis Bullosa Treatment? Cannabis Compound Holds Promise
July 07, 2023
In a positive step for the treatment of the rare genetic dermatological condition known as epidermolysis bullosa (EB), InMed Pharmaceuticals Inc. (NASDAQ: INM) has published top-line data from its...
Via
Benzinga
Marijuana Stock Movers For August 1, 2023
August 01, 2023
Via
Benzinga
Why Are InMed Pharmaceuticals Stock Trading Lower Today
June 22, 2023
InMed Pharmaceuticals Inc (NASDAQ: INM) shares are trading lower after the company released safety and efficacy results from its Phase 2 clinical trial (755-201-EB) for
Via
Benzinga
BioMedNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) 755-201-EB Trial Demonstrates Clinically Important Results
June 22, 2023
Via
Investor Brand Network
Cannabis Stock Movers For July 24, 2023
July 24, 2023
Via
Benzinga
Cannabis Stock Movers For July 20, 2023
July 20, 2023
Via
Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 22, 2023
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.